CA2666308C - Polypeptides ayant des proprietes antiinflammatoires accrues et cytotoxiques reduites et procedes associes - Google Patents
Polypeptides ayant des proprietes antiinflammatoires accrues et cytotoxiques reduites et procedes associes Download PDFInfo
- Publication number
- CA2666308C CA2666308C CA2666308A CA2666308A CA2666308C CA 2666308 C CA2666308 C CA 2666308C CA 2666308 A CA2666308 A CA 2666308A CA 2666308 A CA2666308 A CA 2666308A CA 2666308 C CA2666308 C CA 2666308C
- Authority
- CA
- Canada
- Prior art keywords
- igg
- ivig
- region
- alpha
- source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne un polypeptide contenant au moins une région IgG Fc, ladite région IgG Fc étant glycosylée avec au moins une fonction galactose reliée à une fonction acide sialique terminale respective par une liaison .alpha. 2, 6, et ledit polypeptide ayant une activité antiinflammatoire accrue en comparaison d'un anticorps non purifié.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
USPCT/US06/41791 | 2006-10-26 | ||
PCT/US2006/041791 WO2007055916A2 (fr) | 2005-11-07 | 2006-10-27 | Reactifs, procedes et systemes pour la selection d'un anticorps cytotoxique ou d'une variante |
USPCT/US07/08396 | 2007-04-03 | ||
PCT/US2007/008396 WO2007117505A2 (fr) | 2006-04-05 | 2007-04-03 | Polypeptides presentant des proprietes anti-inflammatoires accrues et des proprietes cytotoxiques reduites, et procedes coorespondants |
PCT/US2007/072771 WO2008057634A2 (fr) | 2006-10-26 | 2007-07-03 | Polypeptides ayant des propriétés antiinflammatoires accrues et cytotoxiques réduites et procédés associés |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2666308A1 CA2666308A1 (fr) | 2008-05-15 |
CA2666308C true CA2666308C (fr) | 2014-09-23 |
Family
ID=40792829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2666308A Active CA2666308C (fr) | 2006-10-26 | 2007-07-03 | Polypeptides ayant des proprietes antiinflammatoires accrues et cytotoxiques reduites et procedes associes |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2010512306A (fr) |
CA (1) | CA2666308C (fr) |
IL (1) | IL197920A0 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR085302A1 (es) * | 2011-02-24 | 2013-09-18 | Sanofi Sa | Metodo de produccion de anticuerpos sialilados |
UY34317A (es) | 2011-09-12 | 2013-02-28 | Genzyme Corp | Anticuerpo antireceptor de célula T (alfa)/ß |
KR102420934B1 (ko) * | 2013-03-11 | 2022-07-15 | 젠자임 코포레이션 | 과글리코실화된 결합 폴리펩티드 |
PT3129067T (pt) | 2014-03-19 | 2023-03-22 | Genzyme Corp | Glicomanipulação em sítios específicos de frações de direcionamento |
KR102549282B1 (ko) * | 2019-11-18 | 2023-06-30 | 건국대학교 산학협력단 | 시알산화된 면역글로불린을 유효성분으로 포함하는 염증성 질환의 치료용 조성물 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2218806T3 (es) * | 1997-01-16 | 2004-11-16 | Neose Technologies, Inc. | Sialilacion practica in vitro de glicoproteinas recombinantes. |
DK2163640T3 (da) * | 1999-04-15 | 2012-03-05 | Crucell Holland Bv | Rekombinant proteinproduktion i en human celle indeholdende mindst ét E1-protein af adenovirus |
CA2424977C (fr) * | 2000-10-06 | 2008-03-18 | Kyowa Hakko Kogyo Co., Ltd. | Procede de purification d'un anticorps |
-
2007
- 2007-07-03 JP JP2009534723A patent/JP2010512306A/ja active Pending
- 2007-07-03 CA CA2666308A patent/CA2666308C/fr active Active
-
2009
- 2009-04-05 IL IL197920A patent/IL197920A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2010512306A (ja) | 2010-04-22 |
CA2666308A1 (fr) | 2008-05-15 |
IL197920A0 (en) | 2011-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230121427A1 (en) | Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods | |
US20220162290A1 (en) | Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods | |
US20080206246A1 (en) | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods | |
WO2008057634A2 (fr) | Polypeptides ayant des propriétés antiinflammatoires accrues et cytotoxiques réduites et procédés associés | |
US20120134988A1 (en) | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods | |
CA2666308C (fr) | Polypeptides ayant des proprietes antiinflammatoires accrues et cytotoxiques reduites et procedes associes | |
NZ597651A (en) | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods | |
US20110150867A1 (en) | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods | |
US20240279314A1 (en) | Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |